Laureate Education vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 44)

Laureate Education

EmergingEducation

General

Baltimore NASDAQ-listed Latin American university operator (LAUR) with 470,000+ students in Mexico/Peru; 2024 revenue $1.54B with 2025 guidance $1.68-1.69B (+7-8%); $150M additional buyback authorized competing for private higher education enrollment.

AI VisibilityBeta
Overall Score
C44
Category Rank
#742 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
35
Perplexity
46
Gemini
41

About

Laureate Education is a Baltimore, Maryland-based international for-profit higher education company — publicly traded on NASDAQ (NASDAQ: LAUR) — operating five university institutions in Mexico and Peru that collectively serve 470,000+ enrolled students (with projections of 494,000 for 2025, +5% year-over-year) through campus-based and online degree programs. In full-year 2024, Laureate generated $1.54 billion in revenue, with 2025 guidance raised to $1.68-1.69 billion (+7-8% year-over-year) and adjusted EBITDA of $508-512 million based on Q3 2025 results. In Q3 2025, Laureate reported $400.2 million quarterly revenue (+9% year-over-year) and authorized an additional $150 million share buyback (adding to $102 million repurchased in 2024). Laureate's five institutions are Universidad del Valle de México (UVM), Universidad Tecnológica de México (UNITEC), and ICEL Universidad in Mexico, and Universidad Privada del Norte (UPN) and Universidad Peruana de Ciencias Aplicadas (UPC) in Peru. CEO Eilif Serck-Hanssen has led the company since 2018. Founded 1989 as Sylvan Learning Systems by Doug Becker; at peak operated 71 institutions across 25 countries before strategic divestiture to current two-country focus.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

44
Overall Score
90
#742
Category Rank
#9
60
AI Consensus
60
stable
Trend
stable
35
ChatGPT
99
46
Perplexity
99
41
Gemini
83
44
Claude
96
53
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.